Applied AI Engineer
PhaseV, a Boston-based technology company founded in 2023, specializes in optimizing clinical development through its enterprise-ready, multi-modal AI/ML platform. The company has secured over $65 million in funding from top investors, positioning itself to significantly impact the drug development process and expedite the delivery of effective treatments to patients.
As an Applied AI Engineer at PhaseV, you will be integral to the development and deployment of scalable, production-grade generative AI pipelines that integrate both unstructured and structured data. Your role will involve researching and developing robust agentic systems to address complex clinical challenges, creating evaluation frameworks for AI systems within clinical contexts, and optimizing representation and retrieval strategies to ensure explainable outputs. Collaboration with cross-functional teams, including engineering, data science, and product, will be essential to drive the company's mission forward.
Ideal candidates should possess a Master's degree in Computer Science, Data Science, Engineering, or a related field, with a strong understanding of Natural Language Processing (NLP), Large Language Models (LLMs), entity recognition, and evaluation techniques. Hands-on experience in building agentic workflows in production environments and working with unstructured data is crucial. Proficiency in Python programming, excellent communication skills, and the ability to thrive in a dynamic, fast-paced environment are also required. Experience in the healthcare or biotech industry and familiarity with clinical data are preferred.
While specific compensation details are not provided, PhaseV offers a competitive salary and benefits package, including health insurance, paid time off, and opportunities for professional development. The company fosters a collaborative and innovative work environment, encouraging team members to contribute to the advancement of clinical development through AI and machine learning.
Joining PhaseV presents an opportunity to be at the forefront of transforming clinical trials, leveraging cutting-edge AI technologies to enhance trial design, execution, and patient outcomes. As the company continues to grow and expand its impact, employees can expect to engage in meaningful work that directly contributes to the acceleration of bringing new therapies to market.